Free Trial
NASDAQ:PRPO

Precipio (PRPO) Stock Price, News & Analysis

$4.69
-0.08 (-1.68%)
(As of 07/12/2024 ET)
Today's Range
$4.31
$4.81
50-Day Range
$4.69
$6.49
52-Week Range
$4.31
$8.99
Volume
5,736 shs
Average Volume
5,678 shs
Market Capitalization
$6.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PRPO stock logo

About Precipio Stock (NASDAQ:PRPO)

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

PRPO Stock Price History

PRPO Stock News Headlines

Exposed: 3 CENT Crypto to Explode June 24th?
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…
Precipio Inc PRPO
Exposed: 3 CENT Crypto to Explode June 24th?
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…
Precipio, Inc. (PRPO)
See More Headlines
Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/14/2024
Today
7/12/2024
Next Earnings (Estimated)
8/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PRPO
Employees
51
Year Founded
N/A

Profitability

Net Income
$-5,850,000.00
Pretax Margin
-31.00%

Debt

Sales & Book Value

Annual Sales
$15.20 million
Book Value
$10.16 per share

Miscellaneous

Free Float
1,313,000
Market Cap
$6.34 million
Optionable
No Data
Beta
1.41
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives


PRPO Stock Analysis - Frequently Asked Questions

How have PRPO shares performed this year?

Precipio's stock was trading at $6.50 at the beginning of 2024. Since then, PRPO shares have decreased by 27.8% and is now trading at $4.69.
View the best growth stocks for 2024 here
.

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) issued its earnings results on Tuesday, May, 14th. The biotechnology company reported ($1.46) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $3.43 million for the quarter. Precipio had a negative net margin of 31.00% and a negative trailing twelve-month return on equity of 46.12%.

When did Precipio's stock split?

Shares of Precipio reverse split on the morning of Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Precipio?

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO) and VBI Vaccines (VBIV).

This page (NASDAQ:PRPO) was last updated on 7/12/2024 by MarketBeat.com Staff

From Our Partners